As of 2025-07-11, the Intrinsic Value of Athira Pharma Inc (ATHA) is -10.21 USD. This Athira valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.42 USD, the upside of Athira Pharma Inc is -2,525.97%.
Based on its market price of 0.42 USD and our intrinsic valuation, Athira Pharma Inc (ATHA) is overvalued by 2,525.97%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -10.21 - -10.21 | -10.21 | -2,525.97% |
P/E | (40.12) - (37.99) | (39.99) | -9597.7% |
DDM - Stable | (15.56) - (41.98) | (28.77) | -6933.8% |
DDM - Multi | (16.51) - (35.25) | (22.55) | -5456.8% |
Market Cap (mil) | 16.44 |
Beta | 2.37 |
Outstanding shares (mil) | 39.04 |
Enterprise Value (mil) | -9.99 |
Market risk premium | 4.60% |
Cost of Equity | 10.78% |
Cost of Debt | 5.00% |
WACC | 7.23% |